Panaxium
PrivateLast Round
Grant
Nov 28, 2025
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Panaxium operates in Healthcare & Life Sciences and is based in Aix-en-Provence. Its latest recorded funding round was a Seed round in April 2023.
Panaxium is a bioelectronic medicine company that develops AI-enabled iontronic neurostimulation therapies and medical equipment to treat brain injuries and restore motor function.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Panaxium Comparables
Compare Panaxium with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurosoft Bioelectronics | 81% | |
| Precision Neuroscience | 75% | |
| Motif Neurotech | 73% |
For institutional investors. Book with your work email.
Panaxium Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 28, 2025 | ||||
| Seed | Apr 10, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Panaxium Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Brain Institute | Seed |
| Centre for Aging and Brain Health Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 182% MoM.
- Jul 28, 2026
Monthly visitors grew 361% MoM, from 82 to 378.
For institutional investors. Book with your work email.
Panaxium Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Panaxium's valuation, stock price, and market status.
Is Panaxium a public or private company?
Panaxium is a private company.
What is the current stock price of Panaxium?
Panaxium is a private company, so its shares have no public market price. Caplight tracks Panaxium's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Panaxium worth (valuation)?
Valuation information for Panaxium is not publicly available.
Can I buy Panaxium stock?
Panaxium shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Panaxium's last funding round?
Panaxium's most recent funding round was Grant on November 28, 2025.
Who are the main investors in Panaxium?
Key investors in Panaxium include Ontario Brain Institute, Centre for Aging and Brain Health Innovation.
Will Panaxium IPO soon?
No public IPO plans have been announced for Panaxium.
How can I track Panaxium secondary market activity?
Caplight tracks bids, offers, and trades in Panaxium's shares on secondary markets.